Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (121-130 of 407) with videos related to

Pageof 41
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
MHC class II expression in lung cancerYayi He, Leslie Rozeboom, Christopher J Rivard, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 21, 2013
Quality of care of patients with non-small-cell lung cancer: a report of a performance improvement initiativeFred R Hirsch, Robert M Jotte, Carolyn A Berry, et al.
Cancer Science|June 15, 2016
Lymphocyte-activation gene-3, an important immune checkpoint in cancerYayi He, Christopher J Rivard, Leslie Rozeboom, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 10, 2017
PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating LymphocytesYayi He, Leslie Rozeboom, Christopher J Rivard, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2016
PIK3CA mutations as prognostic factor in squamous cell lung carcinomaMarc McGowan, Aleksandra Silye Hoven, Marius Lund-Iversen, et al.
Translational Lung Cancer Research|November 19, 2019
Does selected immunological panel possess the value of predicting the prognosis of early-stage resectable non-small cell lung cancer?Xiaoshen Zhang, Yayi He, Keyi Jia, et al.
Critical Reviews in Oncology/Hematology|June 18, 2026
Mitochondrial DNA in Lung Cancer: from biology to clinical implicationsJosé Lucio-Lozada, Diddier Prada, Luiza Beato-González, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case reportRafal Dziadziuszko, Anna Siemiatkowska, Janusz Limon, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2019
Galectin-9 in non-small cell lung cancerYayi He, Keyi Jia, Rafal Dziadziuszko, et al.
Translational Lung Cancer Research|September 27, 2019
OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkersYayi He, Xiaoshen Zhang, Keyi Jia, et al.
Pageof 41

Showing results (121-130 of 407) with videos related to

Sort By:
Pageof 41
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
MHC class II expression in lung cancerYayi He, Leslie Rozeboom, Christopher J Rivard, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 21, 2013
Quality of care of patients with non-small-cell lung cancer: a report of a performance improvement initiativeFred R Hirsch, Robert M Jotte, Carolyn A Berry, et al.
Cancer Science|June 15, 2016
Lymphocyte-activation gene-3, an important immune checkpoint in cancerYayi He, Christopher J Rivard, Leslie Rozeboom, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 10, 2017
PD-1, PD-L1 Protein Expression in Non-Small Cell Lung Cancer and Their Relationship with Tumor-Infiltrating LymphocytesYayi He, Leslie Rozeboom, Christopher J Rivard, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2016
PIK3CA mutations as prognostic factor in squamous cell lung carcinomaMarc McGowan, Aleksandra Silye Hoven, Marius Lund-Iversen, et al.
Translational Lung Cancer Research|November 19, 2019
Does selected immunological panel possess the value of predicting the prognosis of early-stage resectable non-small cell lung cancer?Xiaoshen Zhang, Yayi He, Keyi Jia, et al.
Critical Reviews in Oncology/Hematology|June 18, 2026
Mitochondrial DNA in Lung Cancer: from biology to clinical implicationsJosé Lucio-Lozada, Diddier Prada, Luiza Beato-González, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Unusual chemosensitivity of advanced bronchioalveolar carcinoma after gefitinib response and progression: a case reportRafal Dziadziuszko, Anna Siemiatkowska, Janusz Limon, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2019
Galectin-9 in non-small cell lung cancerYayi He, Keyi Jia, Rafal Dziadziuszko, et al.
Translational Lung Cancer Research|September 27, 2019
OX40 and OX40L protein expression of tumor infiltrating lymphocytes in non-small cell lung cancer and its role in clinical outcome and relationships with other immune biomarkersYayi He, Xiaoshen Zhang, Keyi Jia, et al.
Pageof 41